Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths
- PMID: 21685461
- DOI: 10.3322/caac.20121
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. A total of 1,596,670 new cancer cases and 571,950 deaths from cancer are projected to occur in the United States in 2011. Overall cancer incidence rates were stable in men in the most recent time period after decreasing by 1.9% per year from 2001 to 2005; in women, incidence rates have been declining by 0.6% annually since 1998. Overall cancer death rates decreased in all racial/ethnic groups in both men and women from 1998 through 2007, with the exception of American Indian/Alaska Native women, in whom rates were stable. African American and Hispanic men showed the largest annual decreases in cancer death rates during this time period (2.6% and 2.5%, respectively). Lung cancer death rates showed a significant decline in women after continuously increasing since the 1930s. The reduction in the overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of about 898,000 deaths from cancer. However, this progress has not benefitted all segments of the population equally; cancer death rates for individuals with the least education are more than twice those of the most educated. The elimination of educational and racial disparities could potentially have avoided about 37% (60,370) of the premature cancer deaths among individuals aged 25 to 64 years in 2007 alone. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population with an emphasis on those groups in the lowest socioeconomic bracket. CA Cancer J Clin 2011. © 2011 American Cancer Society.
Similar articles
-
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.Cancer. 2004 Jul 1;101(1):3-27. doi: 10.1002/cncr.20288. Cancer. 2004. PMID: 15221985
-
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. doi: 10.1093/jnci/dji289. J Natl Cancer Inst. 2005. PMID: 16204691
-
Cancer statistics, 2012.CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22237781
-
Breast cancer statistics, 2011.CA Cancer J Clin. 2011 Nov-Dec;61(6):409-18. doi: 10.3322/caac.20134. Epub 2011 Oct 3. CA Cancer J Clin. 2011. PMID: 21969133 Review.
-
Breast cancer statistics, 2013.CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1. CA Cancer J Clin. 2014. PMID: 24114568 Review.
Cited by
-
HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease.Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):675-80. doi: 10.1158/1055-9965.EPI-12-1154. Epub 2013 Feb 8. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23396964 Free PMC article.
-
The modifying effect of patient location on stage-specific survival following colorectal cancer using geosurvival models.Cancer Causes Control. 2013 Mar;24(3):473-84. doi: 10.1007/s10552-012-0134-4. Epub 2013 Jan 10. Cancer Causes Control. 2013. PMID: 23306551 Free PMC article.
-
Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma.Neoplasia. 2012 Dec;14(12):1102-14. doi: 10.1593/neo.121044. Neoplasia. 2012. PMID: 23308043 Free PMC article.
-
Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer.Clin Cancer Res. 2012 Mar 1;18(5):1464-71. doi: 10.1158/1078-0432.CCR-11-2485. Epub 2012 Jan 10. Clin Cancer Res. 2012. PMID: 22235101 Free PMC article.
-
Racial differences and disparities in cancer care and outcomes: where's the rub?Surg Oncol Clin N Am. 2012 Jul;21(3):417-37, viii. doi: 10.1016/j.soc.2012.03.012. Surg Oncol Clin N Am. 2012. PMID: 22583991 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical